Types of insulin include rapid-, regular-, intermediate-, and long-acting, based on how long they take to start working. You may take a combination of these when managing type 2 diabetes.

It’s a major victory for Novo, which is trying to find ways to differentiate itself from Lantus (insulin glargine), which has lost market share after Lilly and Boehringer Ingelheim produced a ...

Semglee has been approved for over a year as a regular biosimilar to Lantus (insulin glargine), meaning that it could be used in place of Sanofi's drug, but only if specifically prescribed for a ...

Long-acting insulin helps people with diabetes maintain normal blood sugar levels throughout the day. Unlike short-acting insulin, it never peaks, keeping an even sugar level in your blood.

Use of insulin glargine U300 increased with chronic kidney disease stage and baseline HbA1c among patients with type 2 diabetes. Glargine U300 (Gla-300) may be safe in management of type 2 diabetes ...

One group received two oral drugs (metformin plus the sulfonylurea glimepiride [Amaryl]) plus morning doses of glargine insulin (Lantus); the other group received twice-daily premixed insulin (70% ...

The interchangeable Semglee product, which will allow substitution of Semglee for the reference product, Lantus(R), at the ... a quality Biosimilar Insulin Glargine.” Biocon Biologics Managing ...